HIF-PH Inhibitor

HIF-PH inhibitors have headed up as a new class of drugs for anemia in patients with CKD (chronic kidney disease). In the early days, ESAs (Erythropoiesis-stimulating agents) were used for the treatment of anemia with CKD complications.